Brief: Annexin Pharmaceuticals Proposes A Fully Guaranteed Rights Issue Of Units Of SEK 73.5 Million

Annexin Pharmaceuticals AB (publ)

21/09/2021 11:06

Sept 21 (Reuters) - Annexin Pharmaceuticals AB (publ)
 ANNX.ST :
    * ANNEXIN PHARMACEUTICALS PROPOSES A FULLY GUARANTEED RIGHTS
ISSUE
OF UNITS OF SEK 73.5 MILLION AND HAS SECURED FURTHER ISSUE
PROCEEDS OF SEK 17 MILLION IN AN THE EXERCISE OF THE WARRANTS IN
APRIL 2022
    * ISSUE PROCEEDS AMOUNT TO A MAXIMUM OF APPROXIMATELY SEK
73.5
MILLION
    * SUBSCRIPTION PERIOD IN RIGHTS ISSUE RUNS BETWEEN OCTOBER
20,
2021 AND NOVEMBER 3, 2021
    * SUBSCRIPTION PRICE IS SEK 1.25 PER UNIT, CORRESPONDING TO
SEK
1.25 PER SHARE. WARRANTS ARE ISSUED FREE OF CHARGE.
    * UPON FULL SUBSCRIPTION IN RIGHTS ISSUE, ANNEXIN RECEIVES
ISSUE
PROCEEDS OF APPROXIMATELY SEK 73.5 MILLION BEFORE ISSUE COSTS
    * FORTHCOMING RIGHTS ISSUE ENABLES CONTINUED WORK WITH
CLINICAL
SAFETY AND EFFICACY STUDIES IN PATIENTS WITH RVO
    * INTENDS TO CONDUCT A PHASE 2 / PROOF OF CONCEPT STUDY TO
DEMONSTRATE SAFETY IN PATIENTS WITH RVO

Source text for Eikon:  ID:nWkr6v7Kkb 
Further company coverage:  ANNX.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))